Second, we show that combining baseline tau-PET with task-fMRI maps of MEM/LAN/EF/VS allows determining personalized cognitive composites with increased sensitivity to detect patient-specific cognitive decline compared to conventional patient-agnostic cognitive composites. This evidence concerns the gene MAPT and Mental deterioration.